Brooks Nader Says ‘So Many Women’ Have Reached Out About GLP-1 Addiction
Brooks Nader was surprised to see an outpouring of support from women from all walks of life after she opened up about her addiction to weight loss drugs. “I didn’t quite know how many other women are going through the same thing that I was going though,” Nader, 28, told Us Weekly exclusively at iHeartRadio’s […]
Risk for Epilepsy Reduced With GLP-1 Receptor Agonist Use in Type 2 Diabetes
MONDAY, Dec. 15, 2025 — For adults with type 2 diabetes mellitus (T2DM), glucagon-like peptide-1 receptor agonist (GLP-1 RA) therapy is associated with a reduced risk for epilepsy, according to a study published online Dec. 10 in…
Lawsuits alleging GLP-1 drugs led to blindness to be centralized
Post Content
Noom Pivots to Longevity: New Program Combines Microdose GLP-1s with At-Home Biomarker Testing
What You Should Know: – Noom has launched Proactive Health Microdose GLP-1Rx, a first-of-its-kind preventive health program designed to intervene before chronic disease takes root. – Available to individuals with a BMI of 21 or higher, the offering combines personalized microdoses of GLP-1 medication with comprehensive at-home biomarker testing and Noom’s digital behavior modification platform. […]
PHTI Report 2025: 5 Strategies for Employers to Manage GLP-1 Costs and Coverage
What You Should Know: – The Peterson Health Technology Institute (PHTI) has released a critical purchasing guide for employers struggling to manage the skyrocketing costs of GLP-1 obesity medications. – The report recommends a shift away from broad, unchecked coverage toward a managed approach focused on three phases: Initiation (strict eligibility), Maintenance (adherence support), and […]
GLP-1 medications may Lower Epilepsy Risk in individuals with type 2 diabetes, according to a recent study. Drugs that mimic the action of the hormone glucagon-like peptide-1 (GLP-1) include semaglutide.
submitted by /u/ranjitsingh7 [link] [comments]
Inclusive Sizing Leaders FullBeauty and Destination XL Combine in ‘Merger of Equals’
Destination XL Group (DXL) and FullBeauty Brands, both giants in the big-and-tall/inclusive-sizing category, will combine in a “merger of equals” with combined net sales of $1.2 billion for the year that ended in October 2025. The deal, which has been approved by both companies’ boards, is expected to generate $25 million in annual run-rate cost […]
The GLP-1 effect: How 2026 will look for food and beverage
From shifting grocery habits to new product opportunities, Circana’s insights reveal how brands and retailers can adapt to the rise of GLP-1 users.
Inspire Medical Systems (INSP) Fell Following Reduced Full-Year Guidance
Wasatch Global Investors, an asset management company, released its third-quarter 2025 “Wasatch Small Cap Growth Strategy” investor letter. A copy of the letter can be downloaded here. US small-cap equities rallied strongly in the third quarter. The Fed Reserve’s interest rate cut supported the rally. However, the fund-Investor Class struggled to keep up with the […]
‘The role of Ozempic isn’t just about reduced consumption, it’s about a shift in values’
Weight loss medications are quietly reshaping how and why people drink, pushing alcohol towards a more selective and health-aware future. James Bayley asks whether health can be pursued without losing autonomy. The rise of GLP-1 medications such as Ozempic is no longer a background murmur for the drinks trade. It is becoming a decisive force […]